Michael Teifel

USPTO Granted Patents = 12 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 56(Granted Patents)

Company Filing History:

7 out of 36

Aeterna Zentaris Gmbh

Medigene Oncology Gmbh

Centre National De La Recherche Scientifique

patents

6. 1 out of 4

University of Montpellier I

patents

7. 1 out of 4

University of Montpellier Ii

patents

where one patent can have more than one assignee

Years Active: 2010-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11644474 - Use of macimorelin in assessing growth hormone deficiency in children (2023-05-09),

2. 9238021 - Method of producing a cationic liposomal preparation comprising a lipophilic compound (2016-01-19),

3. 8912189 - Pyridopyrazine derivatives and their use (2014-12-16),

4. 8791118 - Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors (2014-07-29),

5. 8663606 - Method of producing a cationic liposomal preparation comprising a lipophilic compound (2014-03-04),

6. 8546435 - Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (2013-10-01),

7. 8541462 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors (2013-09-24),

8. 8470776 - Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof (2013-06-25),

9. 8148546 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors (2012-04-03),

10. 8075913 - Method of producing a cationic liposomal preparation comprising a lipophilic compound (2011-12-13),

11. 7794747 - Method of producing a cationic liposomal preparation comprising a lipophilic compound (2010-09-14),

12. 7741277 - Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof (2010-06-22),

Title: The Innovative Contributions of Michael Teifel in Medical Science

Introduction

Michael Teifel, an accomplished inventor based in Weiterstadt, Germany, has made significant strides in the field of medical innovations. With a remarkable portfolio of 12 patents, Teifel continues to drive advancements that enhance healthcare diagnostics and treatment methodologies.

Latest Patents

Among his recent contributions is the innovative patent titled "Use of macimorelin in assessing growth hormone deficiency in children." This invention outlines a method for measuring growth hormone levels in children, focusing on diagnosing pituitary-related growth hormone deficiency. The procedure involves administering macimorelin orally and subsequently collecting blood samples to determine hormone levels, providing a valuable tool for pediatric healthcare.

Another noteworthy patent is the "Method of producing a cationic liposomal preparation comprising a lipophilic compound." This invention describes a technique for creating cationic liposomal preparations that maintain physical and chemical stability. This method not only advances pharmaceutical compositions but also enhances the efficacy of drug delivery systems.

Career Highlights

Michael Teifel has worked prominently at reputable companies in the pharmaceutical industry, including Aeterna Zentaris GmbH and Medigene AG. His expertise in medical innovations has positioned him as a key player in advancing healthcare technology and improving patient outcomes.

Collaborations

Teifel has collaborated with notable professionals in his field, such as Eckhard Guenther and Klaus Paulini. These partnerships have facilitated the development of groundbreaking technologies and have contributed to the enhancement of medical practices.

Conclusion

Michael Teifel’s dedication to innovation in medical science is evident through his numerous patents and collaborations. His work continues to pave the way for advanced healthcare solutions, establishing him as a significant figure in the landscape of medical inventions.

This text is generated by artificial intelligence and may not be accurate.